A
Power Law company profile
Autolus
Biotech & Life Sciences · London, United Kingdom · Founded 2014 · IPO 2018 Unicorn
Valuation
$143M
Market cap · Apr/2026
Revenue
$75M
Latest reported FY
Global footprint
Where Autolus has talent and traffic
Web traffic by country
29K
monthly visits
across markets
across markets
🇺🇸 United States57.9%
🇬🇧 United Kingdom33.1%
🇪🇸 Spain4.5%
🇮🇳 India3.4%
🇩🇪 Germany2.1%
Patent intelligence
$142M patent portfolio · 75 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$142M
98.9% of market cap · 5.5× smaller than top peer BioNTech ($780M)
75 active patent families
Where Autolus innovates
Molecular biologyBinding domainCAR - Chimeric antigen receptorAntigen receptorAntigen binding
Above peer median on Legal
Quality vs same-sector peers
Autolus on the five Patsnap quality dimensions
Autolus in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Autolus concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Autolus and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Autolus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.